Alex Pearson

<i>FGFR1</i> Amplification Drives Endocrine Therapy Resistance and Is a Therapeutic Target in Breast Cancer

Nicholas C. Turner, Alex Pearson, Rachel Sharpe et al. · Cancer Research · 2010 · 738 citations · Full text

Medicine, Cancer Biology, Oncology +17

Integrative molecular profiling of triple negative breast cancers identifies amplicon drivers and potential therapeutic targets

Nicholas C. Turner, Maryou B. Lambros, Hugo M. Horlings et al. · Oncogene · 2010 · 412 citations · Full text

Medicine, Molecular Biology, Oncology +16

High-Level Clonal <i>FGFR</i> Amplification and Response to FGFR Inhibition in a Translational Clinical Trial

Alex Pearson, Elizabeth Smyth, Irina S. Babina et al. · Cancer Discovery · 2016 · 276 citations · Full text

Medicine, Cancer Biology, Oncology +17

Homologous recombination DNA repair deficiency and PARP inhibition activity in primary triple negative breast cancer

Neha Chopra, Holly Tovey, Alex Pearson et al. · Nature Communications · 2020 · 262 citations · Full text

Medicine, Oncology, Pharmacology +16

FGFR Signaling Promotes the Growth of Triple-Negative and Basal-Like Breast Cancer Cell Lines Both <i>In Vitro</i> and <i>In Vivo</i>

Rachel Sharpe, Alex Pearson, María Teresa Herrera-Abreu et al. · Clinical Cancer Research · 2011 · 167 citations · Full text

Life Sciences, Molecular Biology, Oncology +17